Molecular and genetic testing has become a game-changer in brain tumor care – shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these tests are now rapidly being…

Molecular and genetic testing has become a game-changer in brain tumor care – shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these tests are now rapidly being…